Cargando…
Breast Cancer Chemotherapeutic Options: A General Overview on the Preclinical Validation of a Multi-Target Ruthenium(III) Complex Lodged in Nucleolipid Nanosystems
In this review we have showcased the preclinical development of original amphiphilic nanomaterials designed for ruthenium-based anticancer treatments, to be placed within the current metallodrugs approach leading over the past decade to advanced multitarget agents endowed with limited toxicity and r...
Autores principales: | Ferraro, Maria Grazia, Piccolo, Marialuisa, Misso, Gabriella, Maione, Francesco, Montesarchio, Daniela, Caraglia, Michele, Paduano, Luigi, Santamaria, Rita, Irace, Carlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349411/ https://www.ncbi.nlm.nih.gov/pubmed/32517101 http://dx.doi.org/10.3390/cells9061412 |
Ejemplares similares
-
Triple Negative Breast Cancer Preclinical Therapeutic Management by a Cationic Ruthenium-Based Nucleolipid Nanosystem
por: Ferraro, Maria Grazia, et al.
Publicado: (2023) -
Safety and Efficacy Evaluation In Vivo of a Cationic Nucleolipid Nanosystem for the Nanodelivery of a Ruthenium(III) Complex with Superior Anticancer Bioactivity
por: Piccolo, Marialuisa, et al.
Publicado: (2021) -
Antiproliferative effects of ruthenium-based nucleolipidic nanoaggregates in human models of breast cancer in vitro: insights into their mode of action
por: Irace, Carlo, et al.
Publicado: (2017) -
Exploring cellular uptake, accumulation and mechanism of action of a cationic Ru-based nanosystem in human preclinical models of breast cancer
por: Piccolo, Marialuisa, et al.
Publicado: (2019) -
Bioactivity and Development of Small Non-Platinum Metal-Based Chemotherapeutics
por: Ferraro, Maria Grazia, et al.
Publicado: (2022)